Mazzitelli 2

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Merad

France
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Mertens

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Meuris

Belgium
|
2022-2025
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

MISTRA

Italy
|
2017
  • Adults (18-64 years)
  • People at high risk of STIs
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Blood sample

ITM Antwerp Mpox Cohort

Belgium
|
2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Jacobi

Germany
|
2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation

Kröger

Germany
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

Le Vavasseur

France
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

Lehmann

Germany
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Pharmacological intervention
  • Monoclonal antibodies
  • Temelimab

Liira

Finland
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition